Limits prior authorization requirements for rehabilitative and habilitative services. Also prohibits prior authorization for the first twelve (12) visits of a new episode of care and for ninety (90) days following a chronic pain diagnosis.
Prohibits health insurance plans from requiring prior authorization for a new episode of rehabilitative care for twelve visits, or from requiring prior authorization for rehabilitative care for chronic pain for ninety days.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2026.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2026.
Prohibits a policy of individual health insurance coverage from requiring prior authorization for prescriptions of generic medication.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure, or any generic or brand name prescription drug ordered by a primary care provider.
Prohibits prior authorization or a step therapy protocol for the prescription of a nonpreferred medication on their drug formulary used to assess or treat an enrollee's bipolar disorder, schizophrenia or schizotypal.